FLORAHELO
Live / Allowed — Notice of allowance issued (as of 11 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99068237
- Mark type
- Stylized text
- Filed
- 05 Mar 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2025 — ASSIGNED TO EXAMINER
- 25 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 05 Mar 2025 — NEW APPLICATION ENTERED